401 related articles for article (PubMed ID: 27659702)
21. Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).
Scheffer HJ; Vroomen LG; Nielsen K; van Tilborg AA; Comans EF; van Kuijk C; van der Meijs BB; van den Bergh J; van den Tol PM; Meijerink MR
BMC Cancer; 2015 Oct; 15():772. PubMed ID: 26497813
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
[TBL] [Abstract][Full Text] [Related]
23. Ablative safety margin depicted by fusion imaging with post-treatment contrast-enhanced ultrasound and pre-treatment CECT/CEMRI after radiofrequency ablation for liver cancers.
Bo XW; Xu HX; Guo LH; Sun LP; Li XL; Zhao CK; He YP; Liu BJ; Li DD; Zhang K; Wang D
Br J Radiol; 2017 Oct; 90(1078):20170063. PubMed ID: 28749166
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
[TBL] [Abstract][Full Text] [Related]
25. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
26. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
[TBL] [Abstract][Full Text] [Related]
27. Irreversible electroporation in patients with liver tumours: treated-area patterns with contrast-enhanced ultrasound.
Zhou L; Yin S; Chai W; Zhao Q; Tian G; Xu D; Jiang T
World J Surg Oncol; 2020 Nov; 18(1):305. PubMed ID: 33228665
[TBL] [Abstract][Full Text] [Related]
28. Percutaneous Irreversible Electroporation as First-line Treatment of Locally Advanced Pancreatic Cancer.
Månsson C; Brahmstaedt R; Nygren P; Nilsson A; Urdzik J; Karlson BM
Anticancer Res; 2019 May; 39(5):2509-2512. PubMed ID: 31092446
[TBL] [Abstract][Full Text] [Related]
29. Irreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinoma.
Xu K; Chen Y; Su J; Su M; Yan L
J Cancer Res Ther; 2020; 16(2):280-285. PubMed ID: 32474514
[TBL] [Abstract][Full Text] [Related]
30. Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan.
Sugimoto K; Moriyasu F; Tsuchiya T; Nagakawa Y; Hosokawa Y; Saito K; Tsuchida A; Itoi T
Intern Med; 2018 Nov; 57(22):3225-3231. PubMed ID: 29984761
[TBL] [Abstract][Full Text] [Related]
31. Irreversible electroporation in locally advanced pancreatic cancer.
Polyakov AN; Patyutko YI; Kudashkin NE; Kantieva DM; Romanova KA; Nasonova EA; Korshak AV; Egenov OA; Podluzhnyi DV
Khirurgiia (Mosk); 2023; (10):29-38. PubMed ID: 37916555
[TBL] [Abstract][Full Text] [Related]
32. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas.
Dunki-Jacobs EM; Philips P; Martin RC
J Am Coll Surg; 2014 Feb; 218(2):179-87. PubMed ID: 24315888
[TBL] [Abstract][Full Text] [Related]
34. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report.
Scheffer HJ; Melenhorst MC; Vogel JA; van Tilborg AA; Nielsen K; Kazemier G; Meijerink MR
Cardiovasc Intervent Radiol; 2015 Jun; 38(3):760-5. PubMed ID: 25288173
[TBL] [Abstract][Full Text] [Related]
35. A retrospective study of CT-guided percutaneous irreversible electroporation (IRE) ablation: clinical efficacy and safety.
Wang Z; Lu J; Huang W; Wu Z; Gong J; Wang Q; Liu Q; Wang C; Zhu Y; Ding X; Wang Z
BMC Cancer; 2021 Feb; 21(1):124. PubMed ID: 33546635
[TBL] [Abstract][Full Text] [Related]
36. Early nontumorous CT findings after irreversible electroporation of locally advanced pancreatic cancer.
Schulz B; Ou J; Van Meter T; Martin RC
Abdom Radiol (NY); 2016 Nov; 41(11):2142-2149. PubMed ID: 27351439
[TBL] [Abstract][Full Text] [Related]
37. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
[TBL] [Abstract][Full Text] [Related]
38. A Single-institution Experience with Open Irreversible Electroporation for Locally Advanced Pancreatic Carcinoma.
Yan L; Chen YL; Su M; Liu T; Xu K; Liang F; Gu WQ; Lu SC
Chin Med J (Engl); 2016 Dec; 129(24):2920-2925. PubMed ID: 27958223
[TBL] [Abstract][Full Text] [Related]
39. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
[TBL] [Abstract][Full Text] [Related]
40. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
